TherapeuticsMD, Inc. (NASDAQ:TXMD) Short Interest Up 35.1% in February

TherapeuticsMD, Inc. (NASDAQ:TXMD) was the recipient of a large growth in short interest during the month of February. As of February 28th, there was short interest totalling 210,500 shares, a growth of 35.1% from the February 13th total of 155,800 shares. Based on an average trading volume of 531,500 shares, the days-to-cover ratio is currently 0.4 days. Approximately 1.9% of the company’s shares are sold short.

Analysts Set New Price Targets

Separately, StockNews.com assumed coverage on shares of TherapeuticsMD in a research report on Tuesday, January 14th. They issued a “hold” rating on the stock.

TherapeuticsMD Price Performance

Shares of TXMD stock traded up $0.00 on Tuesday, reaching $0.77. 3,022 shares of the company’s stock were exchanged, compared to its average volume of 151,105. The company’s fifty day simple moving average is $0.99 and its 200 day simple moving average is $1.31. TherapeuticsMD has a 52 week low of $0.70 and a 52 week high of $2.61.

TherapeuticsMD Company Profile

TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.